Alliance Pharma plc

LSE (GBp): Alliance Pharma plc (APH)

Last Price

64.51

Today's Change

-0.088 (0.13%)

Day's Change

64.51 - 64.599

Trading Volume

2,311

Overview

Market Cap

349 Million

Shares Outstanding

540 Million

Avg Volume

5,965,721

Avg Price (50 Days)

62.69

Avg Price (200 Days)

48.58

PE Ratio

-32.35

EPS

-0.02

Earnings Announcement

08-Apr-2025

Previous Close

64.70

Open

64.70

Day's Range

64.7 - 64.7

Year Range

24.55 - 66.2

Trading Volume

1,482,300,000

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

0.00%

3 Month Change

1.09%

6 Month Change

34.09%

Ytd Change

40.65%

1 Year Change

96.06%

3 Year Change

-41.71%

5 Year Change

-13.73%

10 Year Change

65.90%

Max Change

20.93%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment